MIR Share Price

Open 0.03 Change Price %
High 0.03 1 Day -0.01 -33.33
Low 0.02 1 Week 0.00 0.00
Close 0.02 1 Month 0.00 0.00
Volume 8600 1 Year -0.02 -50.00
52 Week High 0.05
52 Week Low 0.02
MIR Important Levels
Resistance 2 0.03
Resistance 1 0.03
Pivot 0.02
Support 1 0.01
Support 2 0.01
CVE Canada Most Active Stocks
PRY 0.02 0.00%
PRY 0.02 0.00%
PRY 0.02 0.00%
PRY 0.02 0.00%
COD 0.07 0.00%
COD 0.07 0.00%
COD 0.07 0.00%
DVN 0.17 0.00%
DVN 0.17 0.00%
DVN 0.17 0.00%
More..
CVE Canada Top Gainers Stocks
DDX 0.50 100.00%
BVQ 0.02 100.00%
MIX 0.02 100.00%
MIX 0.02 100.00%
AZU 0.02 100.00%
AZU 0.02 100.00%
RDM 0.21 90.91%
RDM 0.21 90.91%
XL 0.14 75.00%
XL 0.14 75.00%
More..
CVE Canada Top Losers Stocks
FEM 0.02 -50.00%
FEM 0.02 -50.00%
FEM 0.02 -50.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
CZY 0.02 -33.33%
TTM 0.04 -33.33%
More..

MedMira Inc (CVE: MIR)

MIR Technical Analysis 5
As on 20th Jan 2017 MIR Share Price closed @ 0.02 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.04 & Strong Sell for SHORT-TERM with Stoploss of 0.03 we also expect STOCK to react on Following IMPORTANT LEVELS.
MIR Target for January
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
MIR Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.medmira.com
MIR Address
MIR
155 Chain Lake Drive
Suite 1
Halifax, NS B3S 1B3
Canada
Phone: 902-450-1588
MIR Latest News
Is MedMira Inc's (TSXV:MIR) Liquidity As Good As Its Solvency?   Simply Wall St   - 15th Dec 16
MedMira Debuts Reveal(R) G4 Rapid HIV Test at National HIV Prevention Conference   Marketwired (press release)   - 07th Dec 15
MedMira Receives FDA Approval for the Reveal(R) G4 Rapid HIV-1 Antibody Test   Marketwired (press release)   - 19th Oct 15
MedMira opens U.S. office to spur sales, marketing efforts   TheChronicleHerald.ca   - 21st Jul 15
MedMira to partner on colon test   TheChronicleHerald.ca   - 09th Oct 14
MedMira Announces CFO Departure   Canada NewsWire (press release)   - 03rd Dec 13
World Health Org. to assess MedMira's syphilis, HIV test   TheChronicleHerald.ca   - 12th Mar 13
US army contract a 'game changer' for MedMira   TheChronicleHerald.ca   - 04th Jul 12
Swiss-based Andurja takes control of Halifax's MedMira   TheChronicleHerald.ca   - 08th Jun 12
Halifax biotech firms get results in US   TheChronicleHerald.ca   - 05th Apr 12
Interactive Technical Analysis Chart MedMira Inc ( MIR CVE Canada )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on MedMira Inc
MIR Business Profile
MedMira Inc., a biotechnology company, is engaged in the research, development, manufacture, and sale of rapid diagnostics and technology platforms. Its research is focused on specific areas of the diagnostics market, including rapid, point-of-care, and in vitro sectors. Its products include Reveal HIV, which detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal HP/Rapid H. Pylori antibody tests that detect helicobacter pylori (HP) antibodies in serum, plasma, or whole blood produced in response to HP infection; Reveal TP, a rapid syphilis antibody test, which detects treponema pallidum (TP) antibodies; Multiplo, a line of multiplex tests that combines testing solutions for HIV-1/2, Hepatitis B and C, and Syphilis in whole blood, serum, or plasma; and Miriad developer toolkit that facilitates the development and commercialization of rapid diagnostics. MedMira Inc. sells its rapid tests through a network of medical distributors and strategic business development partners with customers in various sectors of the healthcare industry, including laboratories, hospitals, point-of-care facilities, governments, and public health agencies. The company sells and distributes its products in North America, Latin America and the Caribbean, Europe, the Asia Pacific, and the Middle East. MedMira Inc. has collaboration with National Research Council of Canada. The company was founded in 1993 and is headquartered in Halifax, Canada. MedMira Inc. operates as a subsidiary of Onsite Lab Holding AG.